Indian Journal of Surgery

, Volume 81, Issue 5, pp 421–425 | Cite as

Diagnostic Accuracy of Axillary Ultrasound in Early–Stage Breast Cancer

  • Tugba Han YilmazEmail author
  • Hasan Yerli
  • Baha Arslan
  • Varlık Erol
  • Huseyin Gulay
Original Article


Sentinel lymph node biopsy is the standard application for evaluating the axilla in patients with breast cancer. The Z0011 trial conducted by The American College of Surgeons Oncology Group (ACOSOG) revealed that axillary dissection may be redundant in selected patients with positive sentinel node. This raises questions regarding the application of this result to ultrasound-positive patients. This research therefore aimed to evaluate how accurate an ultrasound scan is for axillary node status in early–stage breast carcinoma. The study included 156 newly diagnosed clinical T1–T2, N0 breast cancer patients attending our breast clinic between January 2010 and February 2016. Sentinel lymph node biopsy and axillary lymph node clearance in the presence of sentinel lymph node metastasis was performed on all the breast cancer patients. Axillary ultrasound reports were reviewed retrospectively and the results compared with surgical pathology results. The sensitivity and specificity of axillary ultrasound for detecting axillary lymph node disease was 69.2% and 98%, respectively, with a negative predictive value of 86.4% and positive predictive value of 94.7%. Given the high sensitivity and specificity, and high positive predictive value and negative predictive value demonstrated in the present study, axillary ultrasound represents a potential alternative to sentinel lymph node biopsy for staging of the axilla in early breast cancer. Subsequent trials (SOUND) comparing axillary ultrasound alone with sentinel lymph node biopsy in early breast cancer patients will provide additional information about the subject.


Breast cancer Axillary ultrasound Sentinel lymph node biopsy Preoperative diagnosis 


Compliance with Ethical Standards

Ethics committee approval was received for this study.

Conflict of Interest

The authors declare that they have no conflicts of interest.


  1. 1.
    Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Maisonneuve P, Gatti G, Mazzarol G, de Cicco C, Manfredi G, Fernández JR (2006) Sentinel-lymph node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 7:983–990CrossRefGoogle Scholar
  2. 2.
    Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HMC, Wolmark N (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11:927–933CrossRefGoogle Scholar
  3. 3.
    Ashikaga T, Krag DN, Land SR, Julian TB, Anderson SJ, Brown AM, Skelly JM, Harlow SP, Weaver DL, Mamounas EP, Costantino JP, Wolmark N, National Surgical Adjuvant Breast, Bowel Project (2010) Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 102:111–118CrossRefGoogle Scholar
  4. 4.
    Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE, American College of Surgeons Oncology Group (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657–3663CrossRefGoogle Scholar
  5. 5.
    Giuliano AE, McCall L, Pi B, Whitworth PW, Blumencranz P, Leitch AM et al (2010) Lokoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252:426–432PubMedPubMedCentralGoogle Scholar
  6. 6.
    Holwitt DM, Swatske ME, Gillanders WE, Monsees BS, Gao F, Aft RL, Eberlein TJ, Margenthaler JA (2008) Scientific Presentation Award: the combination of axillary ultrasound and ultrasound-guided biopsy is an accurate predictor of axillary stage in clinically node-negative breast cancer patients. Am J Surg 196:477–482CrossRefGoogle Scholar
  7. 7.
    Verheuvel NC, van den Hoven I, Ooms HW, Voogd AC, Roumen RM (2015) The role of ultrasound guided lymph node biopsy in axillary staging of invasive breast cancer in the post-ACOSOC Z0011 trial era. Ann Surg Oncol 22:409–415CrossRefGoogle Scholar
  8. 8.
    Houssami N, Ciatto S, Turner RM, Cody HS 3rd, Macaskill P (2011) Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla. Ann Surg 254:243–251CrossRefGoogle Scholar
  9. 9.
    Tucker NS, Cyr AE, Ademuyiwa FO, Tabchy A, George K, Sharma PK, Jin LX, Sanati S, Aft R, Gao F, Margenthaler JA, Gillanders WE (2016) Axillary ultrasound accurately excludes clinically significant lymph node disease in patients with early stage breast cancer. Ann Surg 264:1098–1102CrossRefGoogle Scholar
  10. 10.
    Rajesh YS, Ellenbogen S, Banerjee B (2002) Preoperative axillary ultrasound scan: its accuracy in assessing the axillary nodal status in carcinoma breast. Breast 11:49–52CrossRefGoogle Scholar
  11. 11.
    Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351:2817–2826CrossRefGoogle Scholar
  12. 12.
    Habel LA, Shak S, Jacobs MK, Capra A, Alexander C, Pho M, Baker J, Walker M, Watson D, Hackett J, Blick NT, Greenberg D, Fehrenbacher L, Langholz B, Quesenberry CP (2006) A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res 8:R25CrossRefGoogle Scholar
  13. 13.
    de Freitas R Jr, Costa MV, Schneider SV, Colau MAN, Marussi E (1991) Accuracy of ultrasound and clinical examination in the diagnosis of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 17:240–244PubMedGoogle Scholar
  14. 14.
    Yang WT, Ahuja A, Tang A, Suen M, King W, Metreweli C (1996) High resolution sonographic detection of axillary lymph node metastases in breast cancer. J Ultrasound Med 15:241–246CrossRefGoogle Scholar
  15. 15.
    Strauss HG, Lampe D, Methfessel G, Buchman J (1998) Preoperative axilla sonography in breast tumour suspected of malignancy – a diagnostic advantage. Ultraschall Med 19:70–77CrossRefGoogle Scholar
  16. 16.
    Bruneton JN, Caramella E, Héry M, Aubanel D, Manzino JJ, Picard JL (1986) Axillary lymph node metastases in breast cancer: preoperative detection with US. Radiology 158:325–326CrossRefGoogle Scholar
  17. 17.
    Hieken TJ (2014) The promise of axillary imaging in individualized surgical management of breast cancer patients: another step forward. Ann Surg Oncol 21:3369–3371CrossRefGoogle Scholar
  18. 18.
    Verheuvel NC, van den Hoven I, Ooms HW, Voogd AC, Roumen RM (2015) The role of ultrasound-guided lymph node biopsy in axillary staging of invasive breast cancer in the post-ACOSOG Z0011 trial era. Ann Surg Oncol 22:409–415CrossRefGoogle Scholar
  19. 19.
    Boone BA, Huynh C, Spangler ML, Sumkin J, Johnson R, McGuire KP et al (2015) Axillary lymph node burden in invasive breast cancer: a comparison of the predictive value of ultrasound-guided needle biopsy and sentinel lymph node biopsy. Clin Breast Cancer 15:243–248CrossRefGoogle Scholar
  20. 20.
    Weaver DL, Krag DN, Manna EA, Ashikaga T, Waters BL, Harlow SP, Bauer KD, Julian TB (2006) Detection of occult sentinel lymph node micrometastases by immunohistochemistry in breast cancer. An NSABP protocol B-32 quality assurance study. Cancer 107:661–667CrossRefGoogle Scholar
  21. 21.
    Weaver DL, Ashikaga T, Krag DN, Skelly JM, Anderson SJ, Harlow SP, Julian TB, Mamounas EP, Wolmark N (2011) Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med 364:412–421CrossRefGoogle Scholar
  22. 22.
    Mittendorf EA, Ballman KV, McCall LM, Yi M, Sahin AA, Bedrosian I et al (2015) Evaluation of the stage IB designation of the American Joint Committee on cancer staging system in breast cancer. J Clin Oncol 33:1119–1127CrossRefGoogle Scholar
  23. 23.
    Pilewskie M, Jochelson MS, Gooch JC, Patil S, Stempel M, Morrow M et al (2016) Is preoperative axillary imaging beneficial in identifying clinically node-negative patients requiring axillary lymph node dissection? J Am Coll Surg 222:138–145CrossRefGoogle Scholar
  24. 24.
    Tate JJT, Lewis V, Archer T, Guyer PG, Royale GT, Taylor I (1989) Ultrasound detection of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 15:139–141PubMedGoogle Scholar
  25. 25.
    Gentilini O, Veronesi U (2012) Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND). Breast 21:678–681CrossRefGoogle Scholar

Copyright information

© Association of Surgeons of India 2018

Authors and Affiliations

  • Tugba Han Yilmaz
    • 1
    Email author
  • Hasan Yerli
    • 2
  • Baha Arslan
    • 1
  • Varlık Erol
    • 1
  • Huseyin Gulay
    • 1
  1. 1.General Surgery DepartmentBaskent University of Medicine, Baskent Universitesi Zubeyde Hanım Uygulama veArastırma MerkeziİzmirTurkey
  2. 2.Radiology DepartmentBaskent University of Medicine, Baskent Universitesi Zubeyde Hanım Uygulama veArastırma MerkeziİzmirTurkey

Personalised recommendations